跳至主要内容
临床试验/NCT02005055
NCT02005055已完成不适用

Prospective Evaluation of the Use of High-dose-rate Brachytherapy for the Treatment of Recalcitrant Keloids

Amsterdam UMC, location VUmc1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2003年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
43
试验地点
1
主要终点
Recurrence

研究概览

简要总结

This prospective study evaluates the outcome of surgical excision with adjuvant high-dose-rate brachytherapy for the treatment of recalcitrant keloids. Main outcomes are recurrence rate, scar quality and physical complaints.

详细描述

This prospective evaluation describes the outcome of surgical excision with adjuvant high-dose-rate brachytherapy for the treatment of recalcitrant keloids in a large mixed Fitzpatrick skin type patient population. After intralesional excision, a unique low dose radiation scheme of 2x6Gray (Gy) was administered in 2 fractions: the first within 4 hours, the second within 24 hours. Keloids were evaluated pre- and postoperative (1 week, 3, 6, 12 months, 5years). Scars were measured and recurrence was judged. An evaluation of the outcome of the scars was obtained using the Patient and Observer Scar Assessment Scale. Statistical analyses were conducted using SPSS version 20.0 (SPSS, Inc, Chicago, III)

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
10 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Keloid defined as excessive scar tissue raised above skin level and proliferating beyond the confines of the original lesion. Keloids were distinguished from hypertrophic scars based on the clinical judgment of experienced plastic surgeons and on the age of the scar (>1yr)
  • the keloid had been proven insensitive to at least one other treatment
  • patients had to be older than 10 years of age.

排除标准

  • keloids not suitable for excision with primary closure due to its size or anatomical location
  • pregnancy or diabetes

结局指标

主要结局

Recurrence

时间窗: At a minimum of one year post surgery

Recurrence was defined as a growing, pruritic, nodular scar as described by Cosman and Wolff(1)

次要结局

  • Scar Quality(Pre- and postoperative)

研究者

发起方
Amsterdam UMC, location VUmc
申办方类型
Other
责任方
Principal Investigator
主要研究者

Michiel van Leeuwen

MD

Amsterdam UMC, location VUmc

研究点 (1)

Loading locations...

相似试验